+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Transforming growth factor beta inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming growth factor beta inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
From
From
From
Anti-Allergy Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Allergy Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 86 Pages
  • Global
From
Dermatology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
From
From
Advanced Endometrial Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
Loading Indicator